When you participate in a clinical trial, you expect to be fully informed about what will happen. This transparency is the foundation of informed consent—a cornerstone of ethical research. But what if being fully informed might actually compromise the study's results? This is the challenging...
Psychedelic-assisted psychotherapy is showing remarkable promise for treating conditions like depression, PTSD, and addiction. However, a critical issue threatens to undermine this progress: the lack of diverse participants in clinical trials. A recent systematic review reveals that psychedelic research has a serious representation problem that...
Methamphetamine addiction remains one of the most challenging substance use disorders to treat. Traditional approaches often fall short, leaving many individuals and communities struggling with the devastating effects of this powerful stimulant. In New Zealand, an innovative clinical trial is exploring a unique combination of...
Healthcare workers have always faced challenging conditions, but the COVID-19 pandemic pushed many to their breaking point. Long hours, emotional strain, and the constant pressure of life-or-death decisions led to unprecedented levels of burnout and depression among those who care for others. Now, innovative research...